You searched for: adjutec
AdjuTec Pharma’s CEO: “We must restore antibiotics”
A new report from the CDC shows a 460 percent increase in infections with NDM-producing superbugs in the United States since...
AdjuTec Pharma leads €2.2M Eurostars project to combat deadly lung infections
AdjuTec Pharma has signed a €2.2 million Eurostars consortium agreement, spearheading an international effort to combat multidrug-resistant lung infections....
AdjuTec Pharma wants to give new power to antibiotics
Antimicrobial resistance is a growing threat to global health. To address this threat, Oslo-based AdjuTec Pharma is developing...
AdjuTec Pharma's APC148 shines at ESCMID congress
At the recent ESCMID congress, organized by the European Society of Clinical Microbiology and Infectious Diseases, AdjuTec Pharma presented...
AdjuTec Pharma joins forces to fight antibiotic resistance
AdjuTec Pharma has launched a research collaboration with India's Venus Remedies Limited to combat the escalating threat of antimicrobial...
AdjuTec Pharma's CEO: “Our goal is to set a new standard in antibiotic treatment”
Late last year, AdjuTec Pharma launched a phase I clinical trial for its lead candidate, APC148, targeting antimicrobial resistance,...
AdjuTec Pharma enters phase I with novel AMR treatment
AdjuTec Pharma has launched a phase I clinical trial for its leading candidate, APC148, targeting a critical unmet need...
AdjuTec Pharma to start phase I trial with APC148
Adjutec is set to start its phase I clinical trial for the enzyme inhibitor APC148, marking a significant milestone...
AdjuTec advances towards phase I with regulatory green light
Preparing to hit the clinical stage with its antibiotic resistance breakers, Norwegian AdjuTec Pharma recently got a goahead from...
Adjutec applies for phase I start
Norwegian AdjuTec Pharma prepares for clinical trials with its concept for battling antimicrobial resistance. The company recently raised 16...
New proposal potential game changer for Adjutec Pharma
A group of experts from the DRIVE-AB project has introduced a new plan to boost the fight against antimicrobial...
Adjutec CEO on preparing for phase I
AdjuTec Pharma is pioneering in the realm of antimicrobial resistance with its work rooted in research from the University...